US Stock MarketDetailed Quotes
FGEN FibroGen
Watchlist
0.457
+0.014+3.25% Close 11/28 16:00 ET
0.460High0.421Low1.08MVolume
0.445Open0.442Pre Close476.20KTurnover1.28%Turnover RatioLossP/E (TTM)44.92MMarket Cap25.69052wk HighLossP/E (Static)98.34MShares0.33352wk Low-0.29P/B38.62MFloat Cap68.550Historical High--Dividend TTM84.54MShs Float0.333Historical Low--Div YieldTTM8.87%Amplitude0.439Avg Price1Lot Size
About FibroGen Company
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.
Company Profile
SymbolFGEN
Company NameFibroGen
Listing Date11/14/2014
Issue Price18.00
Founded1993
CEOMr. Thane Wettig
MarketNASDAQ
Employees592
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address409 Illinois Street
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158-2509
Phone1-415-978-1200
Websitehttp://www.fibrogen.com
Company Executives
- Name
- Position
- Salary
- Thane Wettig
- Chief Executive Officer and Director
- 3.12M
- Juan Graham
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- 2.15M
- Christine Chung
- Senior Vice President, China Operations
- 3.59M
- James A. Schoeneck
- Chairman of the Board
- 295.85K
- Jeffrey L. Edwards
- Independent Director
- 212.46K
- Jeffrey W. Henderson
- Independent Director
- 198.71K
- Dr. Maykin Ho, PhD
- Independent Director
- 202.46K
- Dr. Aoife M. Brennan, M.B.
- Independent Director
- 199.96K
- Gerald Lema
- Independent Director
- 209.96K
- Suzanne Blaug
- Independent Director
- 214.96K
- Benjamin Cravatt
- Independent Director
- 197.46K
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--